{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T09:23:43Z","timestamp":1719998623944},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hemispherx Biopharma, Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.antiviral.2014.07.010","type":"journal-article","created":{"date-parts":[[2014,8,9]],"date-time":"2014-08-09T16:32:04Z","timestamp":1407601924000},"page":"175-180","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-\u03b1 administered to the buccal mucosa"],"prefix":"10.1016","volume":"110","author":[{"given":"David R.","family":"Strayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce C.","family":"Stouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koert J.","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.M.M.","family":"Thoolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.07.010_b0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra0707279","article-title":"Update on avian influenza A (H5N1) virus infection in humans","volume":"358","author":"Abdel-Ghafar","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.07.010_b0010","first-page":"731","article-title":"Treatment and prevention of acute viral respiratory infections in children with leukocytic interferon","volume":"25","author":"Arnaoudova","year":"1977","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"1","key":"10.1016\/j.antiviral.2014.07.010_b0015","doi-asserted-by":"crossref","first-page":"e1401","DOI":"10.1371\/journal.pone.0001401","article-title":"Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine","volume":"3","author":"Baras","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.07.010_b0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/cc2857","article-title":"Statistics review 10: further nonparametric methods","volume":"8","author":"Bewick","year":"2004","journal-title":"Crit. Care"},{"key":"10.1016\/j.antiviral.2014.07.010_b0025","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/448976b","article-title":"Cheaper approaches to flu divide researchers","volume":"448","author":"Butler","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.07.010_b0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2460\/ajvr.2005.66.164","article-title":"Systemic effects of interferons after oral administration in animals and humans","volume":"66","author":"Cummins","year":"2005","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.antiviral.2014.07.010_b0035","first-page":"162","article-title":"Children\u2019s respiratory viral diseases treated with interferon aerosol","volume":"100","author":"Dai","year":"1987","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.antiviral.2014.07.010_b0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.07.010_b0045","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/aid.1993.9.1115","article-title":"Increased efficacy of human natural interferon alpha (IFN-alpha n3) versus human recombinant IFN-alpha 2 for inhibition of HIV-1 replication in primary human monocytes","volume":"9","author":"Fan","year":"1993","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2014.07.010_b0050","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1128\/JCM.38.11.4096-4101.2000","article-title":"Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene","volume":"38","author":"Fouchier","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0055","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.07.010_b0060","unstructured":"GeneCard, 2014. http:\/\/www.genecards.org\/index.php?path=\/Search\/keyword\/interferon+alpha."},{"key":"10.1016\/j.antiviral.2014.07.010_b0065","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0070","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.010_b0075","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1128\/JVI.05410-11","article-title":"Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses","volume":"85","author":"Javier","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/infdis\/128.2.261","article-title":"Influenza and interferon research in the Soviet Union","volume":"128","author":"Jordan","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.07.010_b0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbapap.2011.07.001","article-title":"Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure","volume":"1824","author":"Kido","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2014.07.010_b0090","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/JVI.02453-08","article-title":"Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets","volume":"83","author":"Kugel","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1354\/vp.40-3-304","article-title":"Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis)","volume":"40","author":"Kuiken","year":"2003","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14787210.2014.870885","article-title":"Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-\u03b1 for infection control and treatment","volume":"12","author":"Liu","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"6","key":"10.1016\/j.antiviral.2014.07.010_b0105","doi-asserted-by":"crossref","first-page":"e29255","DOI":"10.1371\/journal.pone.0029255","article-title":"Exogenous IFN-alpha administration reduces influenza A virus replication in the lower respiratory tract of Rhesus macaques","volume":"2011","author":"Matzinger","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2014.07.010_b0190","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1056\/NEJMp1307009","article-title":"Pandemic Influenza Viruses \u2013 Hoping for the Road Not Taken","volume":"368","author":"Morens","year":"2013","journal-title":"N. Engl. J Med."},{"key":"10.1016\/j.antiviral.2014.07.010_b0110","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1121586","article-title":"Large-scale sequence analysis of avian influenza isolates","volume":"311","author":"Obenauer","year":"2006","journal-title":"Science"},{"issue":"3 Suppl.","key":"10.1016\/j.antiviral.2014.07.010_b0115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1637\/0005-2086-47.s3.931","article-title":"A primate model to study the pathogenesis of influenza A (H5N1) virus infection","volume":"47","author":"Rimmelzwaan","year":"2003","journal-title":"Avian Dis."},{"key":"10.1016\/j.antiviral.2014.07.010_b0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0125","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1128\/JVI.00818-10","article-title":"Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene","volume":"84","author":"Schmeisser","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.07.010_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.24.1.1","article-title":"PDZ domains and the organization of supramolecular complexes","volume":"24","author":"Sheng","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.antiviral.2014.07.010_b0145","first-page":"683","article-title":"The results of controlled observations on the prophylaxis of influenza with interferon","volume":"41","author":"Solov\u2019ev","year":"1969","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.antiviral.2014.07.010_b0150","doi-asserted-by":"crossref","first-page":"e1000756","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.antiviral.2014.07.010_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/jir.2011.0069","article-title":"Recombinant and natural human interferons: analysis of the incidence and clinical impact of neutralizing antibodies","volume":"32","author":"Strayer","year":"2012","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2014.07.010_b0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.antiviral.2014.07.010_b0165","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.cell.2013.05.035","article-title":"Structural determinants for naturally evolving H5N1 hemagglutinin to switch its receptor specificity","volume":"153","author":"Tharakaraman","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.07.010_b0170","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.cell.2013.05.034","article-title":"Glycan receptor binding of the influenza A virus H7N9 hemagglutinin","volume":"153","author":"Tharakaraman","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2014.07.010_b0175","doi-asserted-by":"crossref","first-page":"11566","DOI":"10.1128\/JVI.74.24.11566-11573.2000","article-title":"Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha\/beta interferon","volume":"74","author":"Wang","year":"2000","journal-title":"J. Virol."},{"issue":"202","key":"10.1016\/j.antiviral.2014.07.010_b0180","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/656044","article-title":"Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza","volume":"2010","author":"Wang","year":"2010","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T22:23:31Z","timestamp":1598135011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":36,"alternative-id":["S0166354214002095"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-\u03b1 administered to the buccal mucosa","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}